SUPPLEMENTAL CASH FLOW & OTHER DATA

9 Months Ended

Sep. 30, 2021

Supplemental Cash Flow Elements [Abstract]

SUPPLEMENTAL CASH FLOW & OTHER DATA

SUPPLEMENTAL CASH FLOW AND OTHER DATA

    Supplemental cash flow and other data for the three and nine months ended September 30, 2021 and 2020 was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Depreciation expense	$	76	$	62	$	225	$	186
Amortization expense	25		27		77		77
Depreciation and amortization expense	$	101	$	89	$	302	$	263
Interest expense	$	(38)	$	(42)	$	(114)	$	(126)
Interest income	—		—		—		2
Interest expense, net	$	(38)	$	(42)	$	(114)	$	(124)
Interest paid	$	33	$	33	$	111	$	136
Income taxes paid	$	187	$	148	$	522	$	168
Accounts payable associated with capital expenditures	$	24	$	55	$	24	$	55
Dividends payable	$	77	$	76	$	77	$	76
Businesses acquired:
Fair value of assets acquired	$	20	$	126	$	254	$	377
Fair value of liabilities assumed	—		(9)		(3)		(29)
Fair value of net assets acquired	20		117		251		348
Merger consideration receivable/payable	—		2		—		2
Cash paid for business acquisitions	20		119		251		350
Less: Cash acquired	—		18		—		21
Business acquisitions, net of cash acquired	$	20	$	101	$	251	$	329
Leases:
Leased assets obtained in exchange for new operating lease liabilities	$	46	$	40	$	115	$	119

    

    In March 2020, in response to the COVID-19 pandemic, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was signed into law. In April 2020 and August 2020, the Company received approximately $65 million and $73 million, respectively, of funds that were distributed to healthcare providers for related expenses or lost revenues that are attributable to the COVID-19 pandemic under the CARES Act. The Company accounted for the receipt of the funds under a gain contingency model. Accordingly, the amounts were recognized when the funds were received and the Company determined that it satisfied the associated terms and conditions. During the three months ended June 30, 2020, based on the terms and conditions that were in effect at such time, the Company concluded that it had satisfied such terms and conditions for the $65 million of funds that were received in April 2020 and, therefore, the Company recognized such amount in other operating expense (income), net during the second quarter of 2020. During the three months ended September 30, 2020, the Company reversed the $65 million of funds that had previously been recognized and, during the three months ended December 31, 2020, the Company returned the entire $138 million of funds.